Surgery for advanced and metastatic pancreatic cancer - Current state and perspectives

Anticancer Research

Volumn 26, Issue 1 B, 2006, Pages 681-686

  Mann, Oliver ^a   Strate, Tim ^a   Schneider, Claus ^a   Yekebas, Emre F ^a   Izbicki, Jakob R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Metastatic; Palliative resection; Pancreatic cancer; Review

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; GEMCITABINE; MORPHINE DERIVATIVE; OXALIPLATIN;

ADVANCED CANCER; CANCER INVASION; CANCER PAIN; CANCER STAGING; COMMON BILE DUCT; DIAGNOSTIC IMAGING; ENDOSCOPIC THERAPY; HUMAN; JAUNDICE; LAPAROTOMY; LIVER METASTASIS; MEDICAL DECISION MAKING; METASTASIS; PANCREAS CANCER; PANCREATITIS; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; REVIEW; STENT; SURGICAL TECHNIQUE; SYMPATHECTOMY; VASCULAR DISEASE;

CARCINOMA, PANCREATIC DUCTAL; HUMANS; NEOPLASM METASTASIS; PALLIATIVE CARE; PANCREATIC NEOPLASMS;

EID: 32144453709     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ and Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 54(1): 8-29, 2004.
2. Wray CJ, Ahmad SA, Matthews JB and Lowy AM: Surgery for pancreatic cancer: recent controversies and current practice. Gastroenterology 128(6): 1626-1641, 2005.
3. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C and Neoptolemos JP: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 82(1): 111-115, 1995.
4. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 53(1): 5-26, 2003.
5. Griffin JF, Smalley SR, Jewell W, Paradelo JC, Reymond RD, Hassanein RE and Evans RG: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66(1): 56-61, 1990.
6. Sperti C, Pasquali C, Piccoli A and Pedrazzoli S: Recurrence after resection for ductal adenocarcinoma of the pancreas. World J Surg 21(2): 195-200, 1997.
7. Nitecki SS, Sarr MG, Colby TV and van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221(1): 59-66, 1995.
8. Trede M, Schwall G and Saeger HD: Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 211: 447-458, 1990.
9. Klempnauer J, Ridder GJ, Bektas H and Pichlmayr R: Surgery for exocrine pancreatic cancer - who are the 5- and 10-year survivors? Oncol 52(5): 353-359, 1995.
10. Craighead CC and Lien RC: Pancreatoduodenal resection; comments on indications, operative diagnosis, staged procedures, morbid and lethal factors, and survivals. Ann Surg 147(6): 931-934, 1958.
11. Nakase A, Matsumoto Y, Uchida K and Honjo I: Surgical treatment of cancer of the pancreas and the periampullary region: cumulative results in 57 institutions in Japan. Ann Surg 185(1): 52-57, 1977.
12. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB and Abrams RA: Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226(3): 248-257, 1997.
13. Pellegrini CA, Heck CF, Raper S and Way LW: An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg 124: 778-781, 1989.
14. Birkmeyer JD, Siewers AE, Finlayson EV, Stukel TA, Lucas FL, Batista I, Welch HG and Wennberg DE: Hospital volume and surgical mortality in the United States. N Engl J Med 346(15): 1128-1137, 2002.
15. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE and Lucas FL: Surgeon volume and operative mortality in the United States. N Engl J Med 349(22): 2117-2127, 2003.
16. Gouma DJ, Nieveen van Dijkum EJ, van Geenen RC, van Gulik TM and Obertop H: Are there indications for palliative resection in pancreatic cancer? World J Surg 23(9): 954-959, 1999.
17. Lillemoe KD, Cameron JL, Yeo CJ, Sohn TA, Nakeeb A, Sauter PK, Hruban RH, Abrams RA and Pitt HA: Pancreaticoduodenectomy. Does it have a role in the palliation of pancreatic cancer? Ann Surg 223: 718-725, 1996.
18. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H and Buchler MW: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358(9293): 1576-1585, 2001.
19. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ and Buchler MW: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350(12): 1200-1210, 2004.
20. Moertel CG, Frytak S, Hahn RG, O'Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO Jr, Thomas P, Nave H, Bateman J, Lokich J, Brooks J et al: Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 48(8): 1705-1710, 1981.
21. Menges M, Lerch MM and Zeitz M: The double duct sign in patients with malignant and benign pancreatic lesions. Gastrointest Endosc 52(1): 74-77, 2000.
22. Kalady MF, Peterson B, Baillie J, Onaitis MW, bdul-Wahab OI, Howden JK, Jowell PS, Branch MS, Clary BM, Pappas TN and Tyler DS: Pancreatic duct strictures: identifying risk of malignancy. Ann Surg Oncol 11(6): 581-588, 2004.
23. Pereira-Lima JC, Kromer MU, Adamek HE and Riemann JF: Cholestatic jaundice due to Ormond's disease (primary retroperitoneal fibrosis). Hepatogastroenterol 43(10): 992-994, 1996.
24. Menges M and Pees HW: Kaposi's sarcoma of the pancreas mimicking pancreatic cancer in an HIV-infected patient. Clinical diagnosis by detection of HHV 8 in bile and complete remission following antiviral and cytostatic therapy with paclitaxel. Int J Pancreatol 26(3): 193-199, 1999.
25. Dearden JC, Ayaru L et al: The double duct sign. Lancet 364(9430): 302, 2004.
26. Klempnauer J, Ridder GJ, Piso P and Pichlmayr R: Is liver resection in metastases of exocrine pancreatic carcinoma justified? Chirurg 67(4): 366-370, 1996.
27. Watanapa P and Williamson RC: Surgical palliation for pancreatic cancer: developments during the past two decades. Br J Surg 79: 8-20, 1992.
28. Ohtsuka T, Yamaguchi K, Chijiiwa K, Kinukawa N and Tanaka M: Quality of life after pylorus-preserving pancreatoduodenectomy. Am J Surg 182(3): 230-236, 2001.
29. Hopwood P, Stephens RJ and Machin D: Approaches to the analysis of quality of life data: experiences gained from a Medical Research Council Lung Cancer Working Party palliative chemotherapy trial. Qual Life Res 3(5): 339-352, 1994.
30. Reinders ME, Allema JH, van Gulik TM, Karsten TM, de Wit LT, Verbeek PC, Rauws EJ and Gouma DJ: Outcome of microscopically nonradical, subtotal pancreaticoduodenectomy (Whipple's resection) for treatment of pancreatic head tumors. World J Surg 19: 410-414, 1995.
31. Fuhrman GM, Leach SD, Staley CA, Cusack JC, Charnsangavej C, Cleary KR, El-Naggar AK, Fenoglio CJ, Lee JE and Evans DB: Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group. Ann Surg 223: 154-162, 1996.
32. Leach SD, Lee JE, Charnsangavej C, Cleary KR, Lowy AM, Fenoglio CJ, Pisters PW and Evans DB: Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg 55(5): 611-617, 1998.
33. Bachellier P, Nakano H, Oussoultzoglou PD, Weber JC, Boudjema K, Wolf PD and Jaeck D: Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile? Am J Surg 182(2): 120-129, 2001.
34. Nakagohri T, Kinoshita T, Konishi M, Inoue K and Takahashi S: Survival benefits of portal vein resection for pancreatic cancer. Am J Surg 186(2): 149-153, 2003.
35. Howard TJ, Villanustre N, Moore SA, DeWitt J, LeBlanc J, Maglinte D and McHenry L: Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head. J Gastrointest Surg 7(8): 1089-1095, 2003.
36. Nakano H, Bachellier P, Weber JC, Oussoultzoglou E, Dieng M, Shimura H, Boudjema K, Wolf P and Jaeck D: Arterial and vena caval resections combined with pancreaticoduodenectomy in highly selected patients with periampullary malignancies. Hepatogastroenterol 49(43): 258-262, 2002.
37. Tseng JF, Raut CP, Lee JE, Pisters PW, Vauthey JN, Abdalla EK, Gomez HF, Sun CC, Crane CH, Wolff RA and Evans DB: Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8(8): 935-949, 2004.